PROResmed Inc
stock234.60
+4.55 (+1.98%)
Price as of 13 Oct, 16:48 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Attractive
Attractive investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bullish
4 bull · 0 bear · 0 neutral
Price above 50-day MA
Price above 200-day MA
Price above 12-day EMA
Price above 26-day EMA
Neutral momentum zone
MACD above signal line
Overbought — potential reversal down
Price near upper band — potential reversal
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+4.55
Market Cap
28864770000
Exchange
NYSE
Sector
Health Care
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Resmed Inc
What is Resmed Inc?
ResMed Inc. is a global medical technology company that specializes in developing cloud-connected devices for treating sleep apnea, COPD, and other chronic respiratory conditions. By providing diagnostic tools and therapy machines, they help patients breathe more easily and manage their health remotely through digital health solutions.
Is Resmed Inc a good investment?
The company benefits from a growing demand for respiratory care and a solid reputation for innovation, though it faces risks like supply chain volatility and competition from newer weight-loss medications that may impact demand for its devices. Investors should carefully research current market trends and balance these factors, keeping in mind that this information is for educational purposes and not financial advice.
How do you invest in Resmed Inc?
You can gain exposure to ResMed by purchasing its shares through a regulated brokerage account that provides access to the major stock exchanges where it is listed. Alternatively, you may choose to invest in broader healthcare-focused exchange-traded funds (ETFs) or mutual funds that include ResMed among their underlying holdings.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for RMD — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
No active targets — trend is consolidating.
Famous Investors Holding RMD
Ken Griffin
274.2K sh · 0.0% of portfolio
$53.43M
NEW
Ken Griffin
234.1K sh · 0.0% of portfolio
$45.62M
NEW
Ray Dalio
67.4K sh · 0.1% of portfolio
$13.13M
NEW
Ken Griffin
55.1K sh · 0.0% of portfolio
$10.74M
NEW
Ken Fisher
52.5K sh · 0.0% of portfolio
$10.23M
NEW
Ken Griffin
47.1K sh · 0.0% of portfolio
$9.18M
NEW
Jim Simons
1.6K sh · 0.0% of portfolio
$315.7K
NEW
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.